108 research outputs found
No association between macrolide treatment in infancy and later pyloric stenosis in Sweden
NoneAccepte
Om skandinavismens utförbarhet
Aineisto on Opiskelijakirjaston digitoimaa ja Opiskelijakirjasto vastaa aineiston käyttöluvist
PENGARUH DEWAN KOMISARIS ASING, DEWAN KOMISARIS INDEPENDEN DAN KEPEMILIKAN SAHAM ASING TERHADAP NILAI PERUSAHAAN (STUDI EMPIRIS PADA PERUSAHAAN MANUFAKTUR YANG TERDAFTAR DI BEI TAHUN 2009-2011)
Penelitian ini bertujuan untuk menguji pengaruh dewan komisaris asing, dewan komisaris independen dan kepemilikan saham asing terhadap nilai perusahaan manufaktur yang terdaftar di BEI (Bursa Efek Indonesia) selama periode pengamatan (2009-2011).Penelitian ini merupakan penelitian empiris dengan pendekatan kuantitatif yang melibatkan penggunaan analisa statistik. Penelitian ini menggunakan data sekunder. Alat analisisnyang digunakan dalam penelitian ini adalah regresi linier berganda dengan bantuan
sofware SPSS (Statistical Package for Social Scienc)
Hasil penelitian menunjukkan bahwa dewan komisaris asing dan kepemilikan saham asing berpengaruh positif dan signifikan terhadap nilai perusahaan, sedangkan variabel
dewan komisaris independen tidak mempunyai pengaruh yang signifikan terhadap nilai perusahaan
Cesarean delivery, preterm birth and risk of food allergy : nationwide Swedish cohort study of over 1 million children
Background & Objectives: Little is known about early life risk factors for food allergy in children. We examined the association between perinatal characteristics and future risk of food allergy in offspring.
Methods: This nationwide Swedish cohort study of 1,086,378 children born in Sweden in 2001-2012 used prospectively recorded data from health care registers. Using Cox regression, we estimated hazard ratios (HRs) with 95% confidence intervals (CIs) for the association between perinatal characteristics (e.g. caesarean delivery, preterm birth) and food allergy as defined by diagnoses in the National Patient Register, adjusting for infant sex and maternal factors (age at delivery, country of birth, parity, smoking, body mass index and asthma/pulmonary disease).
Results: During the 13-year follow-up, 26,732 children (2.5%) were diagnosed with food allergy. Food allergy was positively associated with caesarean delivery (HR=1.21; 95%CI=1.18-1.25), large for gestational age (HR=1.15; 95%CI=1.10-1.19) and low 5-minute Apgar score (HR=1.22, 95CI=1.10-1.36) but negatively associated with very preterm birth (<32 weeks of gestation: HR=0.74; 95%CI=0.56-0.98). No association was found between food allergy and moderately preterm birth, low birth weight or small for gestational age. Risk estimates were similar when the outcome was restricted to two records of diagnosed food allergy. In 1,000 children undergoing caesarean delivery, an extra 5 developed food allergy compared with the reference group, suggesting that 17% of food allergy in children born with caesarean delivery can be explained by this exposure (attributable fraction).
Conclusions: Caesarean delivery was associated with increased risk of food allergy, whereas very preterm birth with decreased risk.NoneAccepte
Validation of asthma and eczema in population-based Swedish drug and patient registers
Purpose: Validated measures of asthma and eczema at the population level remain a challenge.
Our aim was to ascertain if register-based information on asthma/eczema medicat
ion can function as a proxy for an asthma/eczema diagnosis and to validate register-based asthma diagnoses.
Methods: Information was requested on all 0-45 year old individuals with reported asthma/eczema
medication and/or diagnoses in
the Swedish Prescribed
Drug Register and National Patient
Register,
between
July 2005 and December 2009 (N=250,691). Medical records for 1,952
randomly selected
individuals were reviewed to estimate
the proportion of individuals with 1)
asthma/eczema medication that fulfilled p
redefined criteria of asthma/eczema (positive predictive
value, PPV); 2) a register-based asthma diagnosis verified as asthma by set criteria.
Results: PPV for asthma by predefined criteria ranged between 0.75 (95% CI: 0.70-0.78) to 0.94 (95% CI: 0.91-0.96), depending on age-group. In pre-school children, PPV for asthma in combination with obstructive bronchitis was 0.87 (95% CI: 0.83-0.90) and PPV for eczema was estimated to 0.45 (95% CI: 0.38-0.51). Eighty percent of children 0-4.5 years and 99% of children >4.5-17 years with a register-based diagnosis of asthma were verified as asthmatics.
Conclusion: Asthma medication is a suitable proxy for asthma in older children and adults; the same approach
is insufficient for eczema. This validation study of two
Swedish registers opens for future large
nation-wide register-based studies on asthma.Swedish Research CouncilVetenskapsrĂĄdetALFManuscrip
Fetal and early life antibiotics exposure and very early onset inflammatory bowel disease – a population-based study
Objective Earlier studies on antibiotics exposure and development of IBD (Crohn’s disease (CD) and ulcerative colitis (UC)) may have been biased by familial factors and gastroenteritis. We aimed to estimate the association between antibiotics during pregnancy or infantile age and very early onset (VEO) IBD.
Design In this cohort study of 827 239 children born in Sweden between 2006 and 2013, we examined the link between exposure to systemic antibiotics and VEO-IBD (diagnosis <6 years of age), using Cox proportional hazard regression models. Information on antibiotics and IBD was retrieved from the nationwide population-based Swedish Prescribed Drug Register and the National Patient Register. We specifically examined potential confounding from parental IBD and gastroenteritis.
Results Children exposed to antibiotics during pregnancy were at increased risk of IBD compared with general population controls (adjusted HR (aHR) 1.93; 95% CI 1.06 to 3.50). Corresponding aHRs were 2.48 (95% CI 1.01 to 6.08) for CD and 1.25 (95% CI 0.47 to 3.26) for UC, respectively. For antibiotics in infantile age, the aHR for IBD was 1.11 (95% CI 0.57 to 2.15); for CD 0.72 (95% CI 0.27 to 1.92) and 1.23 (95% CI 0.45 to 3.39) for UC. Excluding children with gastroenteritis 12 months prior to the first IBD diagnosis retained similar aHR for antibiotics during pregnancy and CD, while the association no longer remained significant for IBD.
Conclusion We found that exposure to antibiotics during pregnancy, but not in infantile age, is associated with an increased risk of VEO-IBD regardless of gastroenteritis. The risk increase for exposure in pregnancy may be due to changes in the microbiota.Financial support was provided from the Swedish Research Council through the Swedish Initiative for Research on Microdata in the Social And Medical Sciences (SIMSAM) framework grant no 340-2013-5867, grants provided by the Stockholm County Council (ALF-projects), the Swedish Heart-Lung Foundation and the Swedish Asthma and Allergy Association’s Research Foundation.Accepte
Antibiotics in fetal and early life and subsequent childhood asthma : nationwide population based study with sibling analysis
OBJECTIVE: To investigate the association between exposure to antibiotics in
fetal and early life and asthma in childhood, with adjustment for confounding
factors.
DESIGN: Nationwide prospective population based cohort study, including
sibling control design.
SETTING: Swedish population identified from national
demographic and health registers.
PARTICIPANTS: 493,785 children born 2006-10;
180,894 of these were eligible for sibling analyses.
MAIN OUTCOME MEASURE: Asthma
defined as having both an asthma diagnosis and dispensed asthma drugs. The
association between antibiotic exposure and asthma was investigated in the whole
cohort with Cox proportional hazard regression. A stratified proportional hazards
model conditional on sibling group was used to adjust for shared factors within
families. Confounding by respiratory infections was assessed by investigating
whether specific groups of antibiotics were associated with asthma.
RESULTS:
Antibiotic exposure in fetal life was associated with an increased risk of asthma
in cohort analyses (hazard ratio 1.28, 95% confidence interval 1.25 to 1.32), but
not in sibling analyses (0.99, 0.92 to 1.07). In cohort analyses, antibiotics
used to treat respiratory infections in childhood were associated with a more
pronounced increased risk of asthma (4.12, 3.78 to 4.50) than antibiotics used
for urinary tract and skin infections (1.54, 1.24 to 1.92). In sibling analyses,
the excess risks after exposure to antibiotics for respiratory infections
decreased (2.36, 1.78 to 3.13) and disappeared for antibiotics for urinary tract
and skin (0.85, 0.47 to 1.55).
CONCLUSIONS: Previous positive associations
between exposure to antibiotics in fetal and early life and subsequent childhood
asthma could have been caused by confounding by shared familial factors, in
addition to confounding by respiratory infections.NonePublishe
Paediatric asthma and non-allergic comorbidities : a review of current risk and proposed mechanisms
It is increasingly recognized that children with asthma are at a higher risk of other non-allergic concurrent diseases than the non-asthma population. A plethora of recent research has reported on these comorbidities and progress has been made in understanding the mechanisms for comorbidity. The goal of this review was to assess the most recent evidence (2016-2021) on the extent of common comorbidities (obesity, depression and anxiety, neurodevelopmental disorders, sleep disorders and autoimmune diseases) and the latest mechanistic research, highlighting knowledge gaps requiring further investigation. We found that the majority of recent studies from around the world demonstrate that children with asthma are at an increased risk of having at least one of the studied comorbidities. A range of potential mechanisms were identified including common early life risk factors, common genetic factors, causal relationships, asthma medication and embryologic origins. Studies varied in their selection of population, asthma definition and outcome definitions. Next, steps in future studies should include using objective measures of asthma, such as lung function and immunological data, as well as investigating asthma phenotypes and endotypes. Larger complex genetic analyses are needed, including genome-wide association studies, gene expression-functional as well as pathway analyses or Mendelian randomization techniques; and identification of gene-environment interactions, such as epi-genetic studies or twin analyses, including omics and early life exposure data. Importantly, research should have relevance to clinical and public health translation including clinical practice, asthma management guidelines and intervention studies aimed at reducing comorbidities.Swedish Research Council (grant no 2018-02640)Swedish Heart-Lung Foundation (grant no 20210416)Publishe
Recommended from our members
Association between pharmacotherapy for ADHD in offspring and depression-related specialty care visits by parents with a history of depression
Background
Pharmacotherapy is effective in reducing the core symptoms of attention-deficit/hyperactivity disorder (ADHD). We aimed to investigate the concurrent association between pharmacotherapy for ADHD in offspring and depression-related specialty care visits by the parents with a history of depression.
Methods
Using data from a variety of Swedish national registers, we conducted a cohort study with 8-year follow-up of 5605 parents (3872 mothers and 1733 fathers) who had a history of depression and an offspring diagnosed with ADHD. The hazard rate for parental depression-related specialty care visits during exposed periods when the offspring was on medication for treatment of ADHD was compared with the hazard rate during unexposed periods when the offspring was off medication. Within-individual comparisons were employed to control for time-constant confounding factors.
Results
Among mothers, the crude rates of depression-related specialty care visits during exposed and unexposed periods were 61.33 and 63.95 per 100 person-years, respectively. The corresponding rates among fathers were 49.23 and 54.65 per 100 person-years. When the same parent was compared with him or herself, fathers showed a decreased hazard rate for depression-related visits during exposed periods when the offspring was on medication for treatment of ADHD as compared to unexposed periods (hazard ratio, 0.79 [95% confidence interval, 0.70 to 0.90]). No statistically significant associations were observed in mothers.
Conclusions
Among parents with a history of depression, pharmacotherapy for ADHD in offspring is concurrently associated with a decreased rate of depression-related specialty care visits in fathers but not in mothers. Future research with refined measures of parental depression and other time-varying familial factors is needed to better understand the mechanisms underlying the association
- …